BenchSci
Toronto
About BenchSci
BenchSci uses AI to empower scientists to run more successful experiments to accelerate drug discovery. The company empowers scientists with advanced biomedical artificial intelligence to run more successful experiments. Backed by F-Prime, Gradient Ventures (Google’s AI fund), and Inovia Capital, BenchSci's proprietary technology accelerates science pharmaceutical companies and over 4,300 research centers worldwide.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: Less than $1M
- Total funding: $164.1M
- Funding stage: Late Stage Venture
- Last round: Series D (May 2023)
- Website: benchsci.com
- Phone: +1 437-370-8077
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Life Science, Machine Learning, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/benchsci-112143 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.